-
J&J broadcasts IPO costs for shopper spinoff Kenvue
Johnson & Johnson products for sale in New York. Scott Mill | CNBC Johnson&Johnson will price shares of its consumer-health spinoff Kenvue at $20 to $23 in an IPO later this year, the company said in a regulatory filing filed Monday. The spinoff, which would be valued at around $40 billion at this share range,…
-
Oxford launch of malaria vaccine might have ‘main’ impression on sub-Saharan Africa, says economist
Close-up of a yellow fever mosquito biting human skin. It is a Culicidae vector of malaria, yellow fever, chikungunya, dengue and Zika virus in Brazil locally known as Mosquito da Dengue. João Paulo Burini | moment | Getty Images Nigeria this week joined Ghana in tentatively approving a new malaria vaccine being developed by Oxford…
-
Senate invoice proposes insulin worth cap for diabetes sufferers
In this photo illustration, Novo Nordisk insulin pens are on display on March 14, 2023 in Miami, Florida. Joe Raedle | Getty Images A bipartisan Senate bill introduced this week would limit the price of insulin to $35 a month for people with private insurance. The bill, drafted by Sens. Jeanne Shaheen, DN.H., and Susan…
-
AI is on the coronary heart of HIMSS to scale back paperwork
Participants of the HIMSS conference walk around the exhibition area Source: HIMSS Debates about artificial intelligence and its role in healthcare were the focus of this week’s HIMSS Global Health Conference in Chicago, which brought together more than 35,000 physicians, other healthcare professionals, executives and engineers to discuss the latest advances in healthcare and technology.…
-
Drug firm CEOs to testify earlier than Senate Well being on insulin worth
Pictured here is a Novo Nordisk insulin pen on display on March 14, 2023 in Miami, Florida. Joe Raedle | News from Getty Images | Getty Images The top executives of the three drug companies that control 90% of the global insulin market will testify before the Senate Health Committee on May 10 about cutting…
-
US choose halts discuss most cancers lawsuits in opposition to Johnson & Johnson
In this image illustration, a Johnson and Johnson baby powder container is on display on April 5, 2023 in San Anselmo, California. Justin Sullivan | Getty Images A federal bankruptcy judge on Thursday halted around 40,000 lawsuits that claimed Johnson&Johnson‘s baby powder and other talc products caused cancer. The decision is part of J&J’s second…
-
Why US furlough coverage is a lot worse than Europe’s
The United States is the only advanced economy that does not guarantee paid time off. “You have entire cultures like France … where pretty much everyone takes August off, and it’s just part of the culture there,” said Shawn Fremstad, director of law and political economy at the Center for Economic and Policy Research. “You…
-
Johnson & Johnson (JNJ) Q1 2023 outcomes
Johnson&Johnson Shares fell on Tuesday after the company reported adjusted earnings and revenue that beat Wall Street expectations but lowered its sales guidance for its pharmaceuticals business. J&J, whose financial results are a guide for many healthcare companies, said its sales for the quarter rose 5.6% from the year-ago quarter. related investment news The consumer…
-
Moderna shares fall regardless of promising most cancers vaccine knowledge
Sopa Pictures | Light Rocket | Getty Images shares of Modern fell on Monday as Wall Street munched over new trial results on the personalized cancer vaccine it is developing note. Merck shares were essentially flat. The experimental mRNA vaccine, when combined with Merck’s blockbuster drug Keytruda, reduces the risk of skin cancer-melanoma recurrence by…
-
Courtroom ruling doesn’t have an effect on 17 states
A US district judge in Washington state said Thursday access to the abortion pill mifepristone was unaffected by a federal appeals court ruling that imposed restrictions on the drug this week. Judge Thomas Rice of the state’s US Eastern District last Friday ordered the Food and Drug Administration to gain access to mifepristone in 17…
